
Generalized Lymphadenopathy due to Chronic Lymphocytic Leukemia (CLL) : 18F-FDG PET Imaging
Author(s) -
Basuki Hidayat,
Febby Hutomo,
Ryan Yudistiro,
Ivana Dewi Mulyanto,
Hendra Budiawan,
Johan S. Masjhur
Publication year - 2016
Publication title -
journal of medicine and health
Language(s) - English
Resource type - Journals
ISSN - 2442-5257
DOI - 10.28932/jmh.v1i3.520
Subject(s) - chronic lymphocytic leukemia , medicine , positron emission tomography , lymphoma , leukemia , differential diagnosis , pet ct , pathology , radiology , nuclear medicine
Lymphadenopaty is a common clinical finding with a broad differential diagnosis, withCarcinoma of Unknown Primary (CUP) as one of it’s most common causes. Flourine-18 fluoro-2 deoxy glucose (18F- FDG) positron emission tomography (PET) is a Nuclear Medicinescintigraphy procedure commonly used to localize suspected a primary lesion by depicting ametabolic status. However, in the expertise of 18F FDG PET study, clinical finding andepidemiologic data must be considered to get a better conclusion. We describe 18F-FDG PETstudy in the presence of generalized lymphadenopathy due to chronic lymphocytic leukemia(CLL), a rare disease which is initially suspected of having CUP.Keywords: 18F-FDG PET, lymphadenopathy, lymphoma, leukemia